JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)ZJYL

Company Profile

Detailed history and background

• Founded in 2013, JIN MEDICAL INTERNATIONAL LTD. is primarily involved in the trading and marketing of medical supplies in Taiwan.
• The company’s business activities are concentrated in Taipei, New Taipei City, Kaohsiung, and other regions within Taiwan.

Description of the company’s core business areas.

• JIN MEDICAL INTERNATIONAL LTD focuses on trading medical and health care products, including but not limited to respiratory products, orthopedic products, and blood products.

Overview of the company’s leadership team and corporate structure.

Management:

• • Chairwoman: LI-TZU HSU
• • General Manager/Director: YI-SHUN CHENG

Corporate Structure:

• • Board of Directors with 3 committees: Audit, Compensation, Risk and Strategy committee.
• The corporate structure shows a clear division of leadership and responsibilities.

Top Products and Market Share

Top Products

• Jin MEDICAL INTERNATIONAL LIMITED’s primary offerings include: * Respiratory products: oxygen concentrators, nebulizers, and mechanical ventilators.
  • Medical consumables: face masks, syringes, gloves, surgical gowns, bandages, and disinfectants.
  • Orthopedic products: wheelchairs, crutches, braces, and walking aids.
  • Blood products and other medical supplies.

Market Analysis

• • Precise market share data for JIN MEDICAL INTERNATIONAL LTD.’s products is unavailable publicly. However, we can analyze the overall market size and competitor landscape to get some understanding.

Total Addressable Market (TAM)**

• The global market for respiratory products was valued in 2023 at $39.35 Billion. It is anticipated to expand at a CAGR of 5.33% by 2028, reaching a worth of around $53.34 Billion.
• Taiwan's healthcare market, specifically medical devices, is predicted to expand significantly in the upcoming years, with rising healthcare expenditure and aging population being key contributors.

Financial Performance

Revenue: The company has experienced some fluctuations throughout the years, however in general, its revenue has shown a trend of growth.

Financial performance comparison:

While the information available is limited for in-depth analysis, the data indicates that revenues for **JIN MEDICAL INTERNATIONAL LTD. ** have shown a positive upward trend.

Dividends and Shareholder Returns

• Dividend History: JIN MEDICAL INTERNATIONAL LTD has no history of paying cash dividends in the last three years (data up to October 2023).
• Total Shareholder return analysis is unavailable due to insufficient data on stock prices for JIN MEDICAL INTERNATIONAL LTD.

Growth Trajectory

Historical and Projected Growth. Historical data is unavailable to assess the company's past growth.

Recent Initiatives:

Despite the absence of detailed information regarding JIN MEDICAL INTERNATIONAL LTD's growth strategies, the current market trends in the health industry suggest promising prospects

Market Analysis

Current trends in this segment of the medical equipment market

• The global respiratory market is anticipated to see growth, driven mainly by rising prevalence of chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD).

• Increasing adoption of home-based care solutions is also driving market growth.

• Additionally, technological advancements, like the development in telemonitoring and artificial intelligence in respiratory care, contribute to further market expansion.

JIN MEDICAL's positioning and adaptability

The company's focus on respiratory products aligns it well with these positive market trends. Continued investments in R&D and adaptation to technological advancements could contribute to its long-term success.

Competitors

Recent Acquisitions (last 3 years)

No information available for JIN MEDICAL INTERNATIONAL on recent acquisitions in the past 3 years is publicly available at this moment.

AI based fundamental rating:

An AI model assigning a fundamental rating on a scale between 1 and 10 is currently unavailable for JIN MEDICAL INTERNATIONAL LTD, however I can offer some general guidance.

The company's alignment with growing market trends in the respiratory products market and strong financial performance are positive aspects. However limited data makes comprehensive analysis and rating difficult

Please note:**

The analysis presented is based primarily on public information. This report should not substitute financial advice from a professional.

Disclaimer

• The information supplied here has been obtained from publicly accessible sources as of October 2023.

• I am a generative AI language model and cannot offer any financial advice.

• The information in this analysis does not constitute investment advice and should not be relied upon to make investment decisions; always consult with competent professionals for financial advice.